These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 8852599

  • 1. CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.
    Nachbaur D, Niederwieser D, Aichinger G, Aulitzky W, Tilg H, Eibl B, König P, Gattringer C, Majdic O, Stockinger H, Margreiter R, Oberhuber G, Födinger AM, Schwaighofer H, Huber C.
    Immunobiology; 1996 Jan; 195(1):33-46. PubMed ID: 8852599
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC, Koenig A, Saison C, Dahdal S, Rigault G, Barba T, Taillardet M, Chartoire D, Ovize M, Morelon E, Defrance T, Thaunat O.
    Front Immunol; 2018 Jan; 9():275. PubMed ID: 29515582
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
    He YG, Ross J, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2723-8. PubMed ID: 1680112
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of accelerated rejection mediated by alloreactive CD4⁺ memory T cells and prolonged allograft survival by arsenic trioxide.
    Yan G, Xi Y, Xu S, Lin Y, Chen J, Dai H, Xia J, Li C, Li Q, Li Z, Qi Z.
    Immunol Invest; 2013 Sep; 42(5):438-54. PubMed ID: 23802174
    [Abstract] [Full Text] [Related]

  • 9. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains.
    Ilano AL, McConnell MV, Gurley KE, Spinelli A, Pearce NW, Hall BM.
    J Immunol; 1989 Nov 01; 143(9):2828-36. PubMed ID: 2572644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar 01; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 13. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH, Bach JF, Chatenoud L.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract] [Full Text] [Related]

  • 14. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP, Ossevoort M, Sick EA, Haanstra K, Jonker M.
    Transpl Immunol; 2003 Feb 01; 11(2):215-22. PubMed ID: 12799206
    [Abstract] [Full Text] [Related]

  • 15. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.
    Shen C, He Y, Cheng K, Zhang D, Miao S, Zhang A, Meng F, Miao F, Zhang J.
    Immunol Lett; 2011 Aug 30; 138(2):144-55. PubMed ID: 21513739
    [Abstract] [Full Text] [Related]

  • 16. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O, Schulze-Garg C, Warnecke G, Gugel R, Löhler J, Deppert W.
    J Virol; 2001 Nov 30; 75(22):10593-602. PubMed ID: 11602701
    [Abstract] [Full Text] [Related]

  • 17. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
    Shi LB, Zhang HW, Peng CH.
    Zhonghua Yi Xue Za Zhi; 2007 Apr 10; 87(14):942-6. PubMed ID: 17650415
    [Abstract] [Full Text] [Related]

  • 18. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J, He F, Wu M, Zheng X, Chen X, Chen Z.
    Transpl Int; 2010 Dec 10; 23(12):1271-81. PubMed ID: 20646257
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Xu S, Chen J, Wang F, Kang X, Lan T, Wang F, Li Z, Qi Z, Xing J.
    Transpl Immunol; 2010 Oct 10; 24(1):57-63. PubMed ID: 20688163
    [Abstract] [Full Text] [Related]

  • 20. Local gene transfer to modulate rat corneal allograft rejection.
    Jessup CF, Brereton HM, Sykes PJ, Thiel MA, Coster DJ, Williams KA.
    Invest Ophthalmol Vis Sci; 2005 May 10; 46(5):1675-81. PubMed ID: 15851568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.